ES392918A1 - Quinoxaline derivatives - Google Patents

Quinoxaline derivatives

Info

Publication number
ES392918A1
ES392918A1 ES392918A ES392918A ES392918A1 ES 392918 A1 ES392918 A1 ES 392918A1 ES 392918 A ES392918 A ES 392918A ES 392918 A ES392918 A ES 392918A ES 392918 A1 ES392918 A1 ES 392918A1
Authority
ES
Spain
Prior art keywords
formula
compounds
residues
racemates
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES392918A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES392918A1 publication Critical patent/ES392918A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

Procedure for obtaining heterocyclic compounds of formula I **(See formula)** wherein R1 and R2, independent of each other, signify hydrogen atoms, alkyl or alkoxy moieties, halogen atoms, trifluoromethyl groups or nitro groups, or together alkylene oxide groups, R3 and R4, in each case, mean a monovalent hydrocarbon moiety or together a bivalent one, which separates the sulfur atoms by a maximum of 4 carbon atoms, optionally substituted, or acyl moieties, and together they also represent a direct bond, R5 and R6, independent of each other, meaning hydrogen atoms or moieties of lower alkyl, or together a residue of formula - (CH2) n, where n is a small integer, characterized in that in a compound of formula **(See formula)** where X means a residue transformable into one of the residues -S-R3 and -S-R4, and R1-R6 have the indicated meanings, the residues X are transformed into the residues + S-R3 and -S-R4 or compounds of formula **(See formula)** are reacted with compounds of the formula **(See formula)** or with functional derivatives thereof, where R1-R6 have the indicated meanings and, if desired, in the obtained compounds, within the range of the final products, the substituents, or/or mixtures of Isomers (mixtures of racemates), optionally obtained, are separated into the pure isomers (racemates), and/or the pure racemates obtained are separated into the optical antipodes, and/or the free compounds obtained are transformed into their salts and salts obtained in the free compounds. (Machine-translation by Google Translate, not legally binding)
ES392918A 1970-07-06 1971-07-05 Quinoxaline derivatives Expired ES392918A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1015970 1970-07-06
CH820271 1971-06-04

Publications (1)

Publication Number Publication Date
ES392918A1 true ES392918A1 (en) 1974-07-01

Family

ID=25702964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES392918A Expired ES392918A1 (en) 1970-07-06 1971-07-05 Quinoxaline derivatives

Country Status (11)

Country Link
AT (2) AT312624B (en)
AU (1) AU3087571A (en)
BE (1) BE769491A (en)
DE (1) DE2132175A1 (en)
ES (1) ES392918A1 (en)
FR (1) FR2100864B1 (en)
GB (1) GB1351342A (en)
HU (1) HU165503B (en)
IE (1) IE35421B1 (en)
IL (1) IL37213A0 (en)
NL (1) NL7109266A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE612972A (en) * 1958-07-10 1900-01-01
US3507870A (en) * 1968-12-18 1970-04-21 Pfizer & Co C 1,4-disubstituted-1,2,3,4-tetrahydrophenazine-5,10-dioxides

Also Published As

Publication number Publication date
GB1351342A (en) 1974-04-24
IE35421L (en) 1971-12-06
IE35421B1 (en) 1976-02-04
FR2100864A1 (en) 1972-03-24
DE2132175A1 (en) 1972-01-13
NL7109266A (en) 1972-01-10
BE769491A (en) 1972-01-05
FR2100864B1 (en) 1974-09-06
AT317228B (en) 1974-08-26
AT312624B (en) 1974-01-10
HU165503B (en) 1974-09-28
IL37213A0 (en) 1971-10-20
AU3087571A (en) 1973-01-17

Similar Documents

Publication Publication Date Title
ES411804A1 (en) (2-imidazolin-2-y(amino) substituted quinolines, -quinoxalines and -quinazolines as antihypertensive agents
ES401616A1 (en) Procedure for the obtaining of 1,4-dihydropyridin-dicharboxylates asymmetrical. (Machine-translation by Google Translate, not legally binding)
SE7601143L (en) NEW OXADIAZOLINE DERIVATIVE
ES422738A1 (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
ES392918A1 (en) Quinoxaline derivatives
ES423104A1 (en) Procedure for preparing heterociclic anilides. (Machine-translation by Google Translate, not legally binding)
ES400587A1 (en) Production of heterocyclic compound
ES389473A1 (en) Derivatives of 3-aminocarbonyl-2-oxazolidinone and their process of preparation
ES419019A1 (en) Indolo-2,3-c quinolinone derivatives
ES395766A1 (en) Procedure for the obtaining of derivatives of hidantoin. (Machine-translation by Google Translate, not legally binding)
ES419439A1 (en) Carbamoyl sulphoxides
ES423826A1 (en) 2-amino-3,4-dihydropyridines
ES402478A1 (en) 1-(cyanoalkoxy) phenoxy-3-amino-2-propanols
ES381036A1 (en) Analgesic drugs based on N- (aroilalkil) n '- (alfanols) piperacinas and their derivatives, and procedure for their obtaination. (Machine-translation by Google Translate, not legally binding)
ES400414A1 (en) Procedure for the preparation of N-substituted piperidine derivatives and their use as stabilizers. (Machine-translation by Google Translate, not legally binding)
ES393554A1 (en) Thiazole derivatives and a process for the manufacture thereof
ES401342A1 (en) Pyridine derivatives
ES400851A1 (en) Optically active benzodiazepines
ES388464A1 (en) Phenoxyethylamines
DE2962515D1 (en) Pyrano-heterocycles, process for their preparation and pharmaceutical compositions containing them
ES398628A1 (en) Procedure for preparation of new methyl-2-dialcohyl-aminomethyl-4- (trimetoxy-3 ', 4', 5'-phenyl) -2-dioxilanes. (Machine-translation by Google Translate, not legally binding)
ES360031A1 (en) Procedure for the preparation of 1,2,4-oxadiazoles isomeros. (Machine-translation by Google Translate, not legally binding)
FR2312255A1 (en) NEW 2,4-BENZOTHIAZEPINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
HUT43585A (en) Process for production of derivatives of piridine and medical compounds containing thereof